+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Juvenile Idiopathic Arthritis Diagnostic Market - Global Forecast 2026-2032- Product Image
Juvenile Idiopathic Arthritis Diagnostic Market - Global Forecast 2026-2032- Product Image
Sale

Juvenile Idiopathic Arthritis Diagnostic Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6128423
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Juvenile Idiopathic Arthritis Diagnostic Market is projected to reach USD 256.30 Million in 2026. It is expected to continue growing at a CAGR of 10.75%, reaching USD 470.56 Million by 2032.

Juvenile Idiopathic Arthritis Diagnostics: Executive Overview

Juvenile idiopathic arthritis (JIA) is a group of chronic inflammatory arthritides beginning before age 16. Diagnosis is clinically complex because symptoms vary by subtype, may evolve over time, and can resemble infection, injury, malignancy, or other autoimmune conditions. No single laboratory test confirms JIA; evaluation generally combines history, physical examination, inflammatory markers, autoantibodies, imaging, and longitudinal observation. Early recognition is important because persistent inflammation can affect joints, growth, vision, mobility, and quality of life.

Earlier Recognition Is Reshaping the Diagnostic Pathway

The diagnostic landscape is shifting from isolated symptom assessment toward coordinated, multidisciplinary evaluation. Pediatric rheumatology, primary care, ophthalmology, radiology, laboratory medicine, and rehabilitation services increasingly contribute to diagnosis and monitoring. Greater attention to uveitis screening, standardized disease classification, musculoskeletal ultrasound, magnetic resonance imaging, and electronic referral pathways is helping clinicians identify inflammatory disease while reducing avoidable delays. At the same time, clinicians must manage the limitations of nonspecific biomarkers and the risk of over-investigating children with noninflammatory musculoskeletal complaints.

Artificial Intelligence Supports Triage, Imaging, and Longitudinal Assessment

Artificial intelligence can strengthen JIA diagnostics by supporting symptom triage, identifying patterns in clinical records, assisting image interpretation, and flagging patients who may require specialist review. Machine-learning systems may also help integrate laboratory findings, imaging, treatment history, and patient-reported outcomes over time. However, performance depends on representative pediatric datasets, consistent diagnostic labels, external validation, and careful oversight. AI should augment-not replace-clinical judgment, particularly where disease subtypes overlap, presentations are atypical, or data are sparse across underserved populations.

Regional Differences Reflect Access, Expertise, and Diagnostic Infrastructure

North America benefits from established pediatric rheumatology networks, advanced imaging, and structured uveitis surveillance, although specialist access remains uneven. Europe has strong clinical guidance and cross-border research collaboration, with variation in referral pathways and access among health systems. Asia-Pacific combines sophisticated specialist services in places such as Australia, Japan, and South Korea with substantial access gaps across rural and lower-resource settings. Latin America faces differences in laboratory availability, specialist density, and continuity of care. The Middle East is expanding pediatric subspecialty capacity, while referral concentration and workforce distribution remain important considerations. Africa continues to face limited specialist coverage, diagnostic-resource constraints, and underrecognition, making training, referral systems, and affordable testing especially significant.

Economic and Alliance Groups Shape Diagnostic Capacity Differently

ASEAN countries show varied access to pediatric rheumatology, imaging, and laboratory services, with urban concentration common across the group. BRICS members span advanced tertiary systems and settings where diagnosis may be delayed by workforce and infrastructure constraints. European Union countries generally operate within strong clinical and research frameworks, though service organization differs nationally. G7 health systems typically have broad access to specialist diagnostics but still encounter regional inequities and capacity pressures. GCC countries are strengthening pediatric specialty services and referral infrastructure, while NATO members collectively include highly diverse healthcare systems; collaboration, interoperability, and shared clinical training can support more consistent care across these groups.

Country-Level Priorities Range From Specialist Access to Integrated Care

Australia, Canada, the United Kingdom, France, Germany, Italy, and Spain have established specialist pathways, but geography and referral timing continue to influence access. The United States combines extensive tertiary expertise with insurance and regional access variation. Japan and South Korea have advanced clinical and imaging capabilities, alongside continued needs for coordinated pediatric referral and standardized longitudinal data. China and India are expanding specialist capacity while facing substantial regional differences in access and diagnostic consistency. Brazil and Mexico must address uneven distribution of pediatric rheumatology and laboratory services. Russia’s diagnostic pathway varies by region and institutional capacity. Across all countries, integration of uveitis screening, imaging, laboratory assessment, and follow-up remains central to high-quality diagnosis.

Practical Priorities for Improving JIA Diagnostic Pathways

Industry and healthcare leaders should prioritize validated referral criteria, pediatric-focused laboratory quality systems, and interoperable records that connect primary care with rheumatology and ophthalmology. Investment should favor tools that complement examination and longitudinal assessment, including point-of-care imaging where appropriate and decision support that clearly communicates uncertainty. AI deployments should use diverse pediatric data, prospective validation, bias monitoring, and clinician override mechanisms. Organizations should also support workforce training, teleconsultation, patient and family education, and outcome tracking focused on diagnostic delay, uveitis detection, functional status, and equitable access rather than technology adoption alone.

Methodology for the Executive Summary

This summary applies a structured clinical and health-system analysis of juvenile idiopathic arthritis diagnostics. It considers the diagnostic role of clinical assessment, inflammatory markers, autoantibodies, imaging, uveitis screening, specialist referral, digital tools, and emerging AI applications. Regional, group, and country observations are framed as qualitative comparisons of healthcare capacity, access, workforce distribution, and care coordination. No market estimates, market shares, forecasts, or company-specific claims are used. Interpretations should be read alongside current pediatric rheumatology guidance and locally applicable clinical standards.

Diagnosis Depends on Coordinated, Equitable, and Evidence-Based Care

JIA diagnosis remains a clinical process requiring time, expertise, and reassessment rather than reliance on a single test. The strongest opportunities lie in earlier referral, consistent examination and imaging practices, systematic uveitis surveillance, and better integration of data across care settings. Artificial intelligence may improve prioritization and pattern recognition, but safe implementation requires transparency, validation, and human oversight. Progress across regions and countries will depend on combining technology with specialist development, accessible services, family engagement, and durable multidisciplinary pathways.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Juvenile Idiopathic Arthritis Diagnostic Market, by Product Type
7.1. Introduction
7.2. Imaging Diagnostics
7.2.1. MRI
7.2.2. Ultrasound
7.2.3. X Ray
7.3. Laboratory Diagnostics
7.3.1. Biomarker Tests
7.3.1.1. Acute Phase Protein Assays
7.3.1.2. Autoantibody Assays
7.3.1.3. Cytokine Assays
7.3.2. Genetic Tests
7.3.3. Serological Tests
8. Juvenile Idiopathic Arthritis Diagnostic Market, by Technology
8.1. Introduction
8.2. ELISA
8.3. Flow Cytometry
8.4. PCR Technology
9. Juvenile Idiopathic Arthritis Diagnostic Market, by End User
9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals
9.4. Research Laboratories
9.5. Specialty Clinics
10. Juvenile Idiopathic Arthritis Diagnostic Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Juvenile Idiopathic Arthritis Diagnostic Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Juvenile Idiopathic Arthritis Diagnostic Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Abbott Laboratories
14.2. Bio-Rad Laboratories, Inc.
14.3. bioMérieux SA
14.4. F. Hoffmann-La Roche AG
14.5. Mayo Clinic
14.6. Ortho Clinical Diagnostics Holdings plc
14.7. QIAGEN N.V.
14.8. Randox Laboratories Ltd
14.9. Siemens Healthineers AG
14.10. Sysmex Corporation
14.11. Thermo Fisher Scientific Inc.
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Juvenile Idiopathic Arthritis Diagnostic Market, Years Considered for the Study
FIGURE 2. Global Juvenile Idiopathic Arthritis Diagnostic Market, Research Design
FIGURE 3. Global Juvenile Idiopathic Arthritis Diagnostic Market, Research Framework
FIGURE 4. Global Juvenile Idiopathic Arthritis Diagnostic Market, Data Triangulation
FIGURE 5. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Juvenile Idiopathic Arthritis Diagnostic Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Juvenile Idiopathic Arthritis Diagnostic Market Segmentation & Coverage
TABLE 2. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 3. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Imaging Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Imaging Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Imaging Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global X Ray Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global X Ray Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global X Ray Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Laboratory Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Laboratory Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Laboratory Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Biomarker Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Biomarker Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Biomarker Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Acute Phase Protein Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Acute Phase Protein Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Acute Phase Protein Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Autoantibody Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Autoantibody Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Autoantibody Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Cytokine Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Cytokine Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Cytokine Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Genetic Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Genetic Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Genetic Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Serological Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Serological Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Serological Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 38. Global ELISA Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global ELISA Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global ELISA Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global PCR Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global PCR Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global PCR Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 48. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Research Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Research Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Research Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. North America Juvenile Idiopathic Arthritis Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. North America Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 70. North America Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 71. North America Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 72. North America Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 73. North America Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 74. North America Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 78. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 79. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 80. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 81. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 85. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 86. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 87. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 88. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Middle East Juvenile Idiopathic Arthritis Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Middle East Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 91. Middle East Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 92. Middle East Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 93. Middle East Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 94. Middle East Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 95. Middle East Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Africa Juvenile Idiopathic Arthritis Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Africa Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 98. Africa Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 99. Africa Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 100. Africa Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 101. Africa Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 102. Africa Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. ASEAN Juvenile Idiopathic Arthritis Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. ASEAN Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 106. ASEAN Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 107. ASEAN Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 108. ASEAN Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 109. ASEAN Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 110. ASEAN Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. GCC Juvenile Idiopathic Arthritis Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. GCC Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. GCC Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 114. GCC Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 115. GCC Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 116. GCC Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 117. GCC Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. European Union Juvenile Idiopathic Arthritis Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. European Union Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. European Union Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 121. European Union Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 122. European Union Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 123. European Union Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 124. European Union Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. BRICS Juvenile Idiopathic Arthritis Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. BRICS Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. BRICS Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 128. BRICS Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 129. BRICS Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 130. BRICS Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 131. BRICS Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. G7 Juvenile Idiopathic Arthritis Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. G7 Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 134. G7 Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 135. G7 Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 136. G7 Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 137. G7 Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 138. G7 Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. NATO Juvenile Idiopathic Arthritis Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. NATO Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. NATO Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 142. NATO Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 143. NATO Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 144. NATO Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 145. NATO Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. United States Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 148. United States Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. United States Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 150. United States Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 151. United States Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 152. United States Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 153. United States Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Canada Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 155. Canada Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. Canada Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 157. Canada Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 158. Canada Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 159. Canada Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 160. Canada Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Mexico Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 162. Mexico Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Mexico Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 164. Mexico Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 165. Mexico Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 166. Mexico Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 167. Mexico Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. Brazil Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 169. Brazil Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. Brazil Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 171. Brazil Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 172. Brazil Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 173. Brazil Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 174. Brazil Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. United Kingdom Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 176. United Kingdom Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. United Kingdom Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 178. United Kingdom Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 179. United Kingdom Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 180. United Kingdom Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 181. United Kingdom Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Germany Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 183. Germany Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. Germany Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 185. Germany Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 186. Germany Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 187. Germany Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 188. Germany Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. France Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 190. France Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. France Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 192. France Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 193. France Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 194. France Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 195. France Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Russia Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 197. Russia Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. Russia Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 199. Russia Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 200. Russia Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 201. Russia Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 202. Russia Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Italy Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 204. Italy Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. Italy Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 206. Italy Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 207. Italy Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 208. Italy Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 209. Italy Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Spain Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 211. Spain Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. Spain Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 213. Spain Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 214. Spain Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 215. Spain Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 216. Spain Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. China Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 218. China Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. China Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 220. China Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 221. China Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 222. China Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 223. China Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. India Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 225. India Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. India Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 227. India Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 228. India Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 229. India Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 230. India Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Japan Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 232. Japan Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 233. Japan Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 234. Japan Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 235. Japan Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 236. Japan Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. Japan Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. Australia Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 239. Australia Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. Australia Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 241. Australia Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 242. Australia Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 243. Australia Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 244. Australia Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 246. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 247. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Size, by Imaging Diagnostics, 2017-2032 (USD Million)
TABLE 248. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Size, by Laboratory Diagnostics, 2017-2032 (USD Million)
TABLE 249. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Size, by Biomarker Tests, 2017-2032 (USD Million)
TABLE 250. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 251. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Global Juvenile Idiopathic Arthritis Diagnostic Market Share, by Key Player, 2025
TABLE 253. Global Juvenile Idiopathic Arthritis Diagnostic Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche AG
  • Mayo Clinic
  • Ortho Clinical Diagnostics Holdings plc
  • QIAGEN N.V.
  • Randox Laboratories Ltd
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Diagnostic Testing Market Report and Forecast 2025-2034 - Product Image

Diagnostic Testing Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
United States Diagnostics Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

United States Diagnostics Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 85 Pages
  • United States
From
Biological Age and Longevity Diagnostics Market Global Report 2026 - Product Image

Biological Age and Longevity Diagnostics Market Global Report 2026

  • Report
  • 250 Pages
  • Global
From
Juvenile Idiopathic Arthritis Diagnostic Market Report 2026 - Product Image

Juvenile Idiopathic Arthritis Diagnostic Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Juvenile Idiopathic Arthritis (JIA) - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Image

Juvenile Idiopathic Arthritis (JIA) - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • 225 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.